27. WHO PREQUALIFICATION FOR MEASLES VACCINE MVVAC PRODUCED BY POLYVAC: CHALLENGES AND LESSONS LEARNED

Pham Thi Phuong Thao1, Luong Phu Duan1, Le Thu Nga1, Le Thi Hoa1, Nong Thi Thanh Van1, Nguyen Thi Mai Huong1, Nguyen Thi Bich Ngoc1, Tran Minh Nguyet1, Le Quoc Hung1, Pham Anh Thu1, Nguyen Xuan Hoa1, Pham Thanh Truong1, Le Tuan Anh1, Nguyen Dang Anh1, Nguyen Dang Hien1, Nguyen Thuy Huong1
1 Center for Research and production of Vaccines and Biologicals, Hanoi

Main Article Content

Abstract

Prequalification (PQ) is the WHO’s comprehensive assessment of the quality, safety and effectiveness of vaccines to be purchased by UNICEF or other organizations of the United Nations. In Vietnam, there are 4 manufacturers producing vaccines, providing for the National Expanded Immunization Program to ensure domestic vaccine supply chain. Currently, Center for Research and Production of Vaccines and Biologicals (POLYVAC) is the first manufacturer to submit an application to WHO-PQ from May 31, 2021 for MVVAC Measles vaccine. This report aimed to provide useful information about the detailed process and legal requirements for applying to WHOPQ for vaccines. The article also mentioned common difficulties in the process of applying for PQ for products manufactured in Vietnam due to differences in procedures and requirements of WHO and Vietnam as well as responding to updates in WHO regulations. In addition, we also shared some of POLYVAC’s practical challenges and solutions to achieve initial successes. Therefore, other vaccine manufacturers in Vietnam can refer to the information and have lessons learned to prepare for WHOPQ applications in the future.

Article Details

References

[1] WHO, TRS 978. Procedure for assessing the
acceptability, in principle, of vaccines for
purchase by United Nations agencies, Annex
6, 2013
[2] WHO, Vaccines Prequalification Priority List,
2023. https://extranet.who.int/prequal/vaccines/
vaccines-eligible-who-prequalification Ngày
truy cập 13/12/2023
[3] WHO/IVB/14.10 Assessing the programmatic
suitability of vaccine candidates for WHO
prequalification, 2014
[4] Bộ Y tế, Thông tư 08/2022/TT-BYT quy định
việc đăng ký lưu hành thuốc, nguyên liệu làm
thuốc, ký ngày 05 tháng 9 năm 2022.
[5] Debbie Jordan, An overview of the Common
Technical Document (CTD) regulatory
dossier, Medical Writing, 23:2, 2014, 101-105
[6] Dellepiane N, Pagliusi S, Registration Experts
Working Group. Challenges for the registration
of vaccines in emerging countries: Differences in
dossier requirements, application and evaluation
processes. Vaccine. 2018 Jun 7;36(24):3389-
3396
[7] WHO, Health products policy and standards.
https://www.who.int/teams/health-product-andpolicy-
standards/standards-and-specifications/
norms-and-standards-for-pharmaceuticals/
guidelines/production, ngày truy cập 13/12/2023
[8] EU-GMP, Manufacture of Sterile Medicinal
Products, Annex 1, 2022